Table 1 Associations of PODXL expression with clinicopathological factors
Entire cohort | PODXL neg | PODXL pos | ||
|---|---|---|---|---|
n (%) | n (%) | n (%) | p-value | |
171 (100.0) | 29 (17.0) | 142 (83.0) | ||
Age | ||||
≤70 | 85 (49.7) | 12 (41.4) | 73 (51.4) | 0.416 |
>70 | 86 (50.3) | 17 (58.6) | 69 (48.6) | |
Sex | ||||
Female | 39 (22.8) | 9 (31.0) | 30 (21.1) | 0.330 |
Male | 132 (77.2) | 20 (69.0) | 112 (78.9) | |
T stage | ||||
T1 | 18 (10.5) | 2 (6.9) | 16 (11.3) | 0.637 |
T2 | 32 (18.7) | 6 (20.7) | 26 (18.3) | |
T3 | 94 (55.0) | 16 (55.2) | 78 (54.9) | |
T4 | 27 (15.8) | 5 (17.2) | 22 (15.5) | |
N stage | ||||
N0 | 57 (33.3) | 16 (55.2) | 41 (28.9) | 0.006 |
N1 | 29 (17.0) | 4 (13.8) | 25 (17.6) | |
N2 | 41 (24.0) | 6 (20.7) | 35 (24.6) | |
N3 | 44 (25.7) | 3 (10.3) | 41 (28.9) | |
M stage | ||||
M0 | 152 (88.9) | 25 (86.2) | 127 (89.4) | 0.535 |
M1 | 19 (11.1) | 4 (13.8) | 15 (10.6) | |
R classification | ||||
R0 | 117 (68.4) | 22 (75.9) | 95 (66.9) | 0.556 |
R1 | 45 (26.3) | 5 (17.2) | 40 (28.2) | |
R2 | 9 (5.3) | 2 (6.9) | 7 (4.9) | |
Differentiation grade | ||||
Low grade | 8 (4.7) | 4 (13.8) | 4 (2.8) | 0.023 |
Intermediate grade | 52 (30.4) | 10 (34.5) | 42 (29.6) | |
High grade | 111 (64.9) | 15 (51.7) | 96 (67.6) | |
Lauren classification | ||||
Intestinal | 119 (69.6) | 23 (79.3) | 96 (67.6) | 0.335 |
Mixed | 9 (5.3) | 0 (0.0) | 9 (6.3) | |
Diffuse | 43 (25.1) | 6 (20.7) | 37 (26.1) | |
Location | ||||
Esophagus + EG junction | 106 (62.0) | 15 (51.7) | 91 (64.1) | 0.217 |
Stomach | 65 (38.0) | 14 (48.3) | 51 (35.9) | |